EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ClearPoint Neuro's Enterprise Value is $135.08 Mil.
ClearPoint Neuro's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.77 Mil. Therefore, ClearPoint Neuro's EV-to-FCF for today is -9.15.
The historical rank and industry rank for ClearPoint Neuro's EV-to-FCF or its related term are showing as below:
CLPT'
s EV-to-FCF Range Over the Past 10 Years
Min: -59.29 Med: -9.32 Max: -0.76
Current: -9.15
During the past 13 years, the highest EV-to-FCF of ClearPoint Neuro was -0.76. The lowest was -59.29. And the median was -9.32.
CLPT's EV-to-FCF is ranked worse than 100% of 369
companies
in the Medical Devices & Instruments industry
Industry Median: 27.47
vs CLPT: -9.15
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for ClearPoint Neuro's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ClearPoint Neuro's EV-to-FCF
For the Medical Devices subindustry, ClearPoint Neuro's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClearPoint Neuro's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ClearPoint Neuro's EV-to-FCF falls into.
ClearPoint Neuro's current Enterprise Value is $135.08 Mil.
ClearPoint Neuro's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.77 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClearPoint Neuro (NAS:CLPT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
ClearPoint Neuro's PE Ratio for today is calculated as:
ClearPoint Neuro's share price for today is $5.45.
ClearPoint Neuro's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.910.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
ClearPoint Neuro EV-to-FCF Related Terms
Thank you for viewing the detailed overview of ClearPoint Neuro's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
ClearPoint Neuro (ClearPoint Neuro) Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPT has been successfully added to your 